Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02044939
Other study ID # 2011_23/1917
Secondary ID 2012-A00347-36
Status Terminated
Phase N/A
First received
Last updated
Start date July 10, 2012
Est. completion date June 2018

Study information

Verified date June 2018
Source University Hospital, Lille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary objective of the study is to assess the improvement of daily activity in subjects with Stage IV Pulmonary Sarcoidosis one year after the conduct of a pulmonary rehabilitation program.

The secondary objectives are the following:

- assess the improvement of daily activity at several times : 2, 6 and 12 months after the beginning of a pulmonary rehabilitation program

- assess the improvement of exercise capacity by tests used in medical practice

- assess the correlation between daily activity and exercise capacity

- assess the improvement of dyspnea

- assess the improvement of quality of life and psychological state


Description:

The primary objective of the study is to assess the improvement of daily activity in subjects with Stage IV Pulmonary Sarcoidosis one year after the conduct of a pulmonary rehabilitation program

The secondary objectives are the following :

- assess the improvement of daily activity at several times : 2, 6 and 12 months after the beginning of a pulmonary rehabilitation program

- assess the improvement of exercise capacity by tests used in medical practice

- assess the correlation between daily activity and exercise capacity

- assess the improvement of dyspnea

- assess the improvement of quality of life and psychological state


Recruitment information / eligibility

Status Terminated
Enrollment 36
Est. completion date June 2018
Est. primary completion date June 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Stage IV Sarcoidosis

- No hospitalization for respiratory distress in the 3 months preceding the inclusion

- Dyspnea on exertion

- Age over 18 years

Exclusion Criteria:

- Physical disability does not allow the creation of a rehabilitation program

- Inability to give written consent to the study

- Refusal of contraception in women of childbearing age

- Inability to participate in the entire study

- No cover by the social security system

- Inability to perform self-questionnaires etude

The trial does not include special populations include:

- Pregnant women

- Breastfeeding women

- People in emergencies

- Persons unable to consent

- Persons deprived of liberty

Study Design


Intervention

Other:
Pulmonary rehabilitation program
Pulmonary rehabilitation program should follow ATS/ERS Guidelines (2006)

Locations

Country Name City State
France Service de Pneumologie, CH Arras Arras
France Service de Pneumologie, CH Béthune Béthune Pas De Calais
France Service de pneumologie, Hôpital Avicenne AP-HP Bobigny
France Clinique des Maladies Respiratoires, CHRU de LILLE Lille Nord
France CHU Nord, APHM Marseille Marseille
France Service de Pneumologie, Hôpital Pasteur - Pavillon H, CHU de Nice Nice
France Service de Pneumologie, Hôpital européen Georges Pompidou. AP-HP Paris
France Centre Hospitalier Lyon Sud Pierre Benite
France Hôpital Maison Blanche, CHU de Reims Reims
France Service de Pneumologie, Hôpital Victor Provo Roubaix
France Clinique des Voies Respiratoires, Hôpital Larrey Toulouse

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Lille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Daily activity assessed by time (in minutes) spent in moderate activity (superior to 2,5 MET) In everyday life, it corresponds to a walking in 5 km/h or in domestic chores. This measure will be realized by using Armband's accelerometer, in ambulatory. The measure will be realized over a period of 4 full days including the weekend. 12 months
Secondary Daily activity assessed by time spent in moderate activity (superior to 2,5 MET) 2 and 6 months
Secondary exercise capacity assessed by symptom-limited cardiopulmonary exercise test, 6 minutes walk test, endurance test on bicycle, St Etienne questionnaire, 6 minutes stepper test 2, 6 and 12 months
Secondary MRC scale for dyspnea 2, 6 and 12 months
Secondary Questionnaire to evaluate quality of life and/or psychological state : VSRQ 2, 6 and 12 months
Secondary Questionnaire to evaluate quality of life and/or psychological state : MRF 28 2, 6 and 12 months
Secondary Questionnaire to evaluate quality of life and/or psychological state : HAD 2, 6 and 12 months
Secondary Questionnaire to evaluate quality of life and/or psychological state : FAS 2, 6 and 12 months
Secondary Questionnaire to evaluate quality of life and/or psychological state : DIRECT 2, 6 and 12 months